Methods: This study used a quasi-experimental design with purposive sampling at a mental health clinic specializing in ERP with an established weekly peer-led OCD support group. English versions of the Yale-Brown Obsessive-Compulsive Scale – Self Report (-Y-BOCS-SR) (Goodwin, Price, Rasmussen, et al., 1989) and the Quality-of-Life Enjoyment and Satisfaction Questionnaire – Short Form (Q-LES-Q-SF) (Endicott, Nee, Harrison, & Blumenthal) were administered to subjects in individual outpatient (n=6) and subjects in group and individual ERP (n=6) prior to week 1 (baseline/pre) session and after week 6 (post) session, outside of session time. Descriptive statistics were calculated for the group characteristics. Group differences were assessed using t-tests when possible; however, to look at clinical group-level effects while controlling for within-subject change, Hedge’s g scores (using a pooled standard deviation) were also calculated. R (v4.0.3) and Excel were used to analyze the data.
Results: Controlling for within-subject change and looking at hedge’s g scores showed clinical effects of the peer-group. Q-LES-Q-SF current health or work life scores indicated an overall positive change in the quality of life for peer-group recipients (g=0.51). Peer-group participants together indicated a larger reduction in obsessions on average (M=-1.8, SD=2.2) than individual ERP only participants (M=-0.5, SD=2.7), with a modest between group effect difference (g=-0.55). The compulsions scores showed a larger average decline for individual session only participants (M=-2.0, SD=1.9) versus peer support participants (M=-1.2, SD=1.8). This effect was in the direction of the individual support group (g=0.45). Overall, the combined 10-item scale showed a small, combined benefit for the peer-group participants (g=-0.14).
Conclusions and Implications: This study showed early trends in positive change in ERP treatment enhancement and quality of life scores for subjects adding a brief peer-led OCD support group delivered conjointly to individual ERP treatment. Additional research is needed to fully assess effectiveness; however, trends were overall positive.